(Q34585521)

English

Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION).

scientific article

Statements

Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION). (English)
0 references
0 references
0 references
28 November 2007

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit